Bay City Capital

US genomics startup Omicia picks up $6.8M in Series A round

California, US-based clinical genomic startup Omicia has raised $6.8 million in a Series A round led by Artis Ventures for the expansion of its marketing efforts and optimization of its big data offerings.

Read Full Article

Pharmakea's Series A funding round receives investment from Bay City Capital

Pharmakea Therapeutics receive funding through Series A round from Bay City Capital and Celgene Corporation.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics